The Technical Analyst
Select Language :
Reneo Pharmaceuticals, [RPHM]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Reneo Pharmaceuticals, Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Reneo Pharmaceuticals, is listed at the  Exchange

0.00% $1.650

America/New_York / 27 mar 2024 @ 16:00


Reneo Pharmaceuticals,: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 54.96 mill
EPS: -2.36
P/E: -0.700
Earnings Date: Mar 24, 2024
SharesOutstanding: 33.31 mill
Avg Daily Volume: 0.378 mill
RATING 2024-03-27
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Sell
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.700 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.12x
Company: PE -0.700 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.754
(-54.32%) $-0.896
Date: 2024-03-28
Expected Trading Range (DAY)

$ 1.576 - 1.724

( +/- 4.48%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-08-28 Hall Ashley Sell 15 625 Stock option (right to buy)
2023-08-28 Hall Ashley Buy 15 625 Common Stock
2023-08-28 Hall Ashley Sell 15 625 Common Stock
2023-07-26 Grey Michael G Sell 50 000 Common Stock
2023-06-23 Novo Holdings A/s Sell 100 000 Common Stock
INSIDER POWER
50.37
Last 95 transactions
Buy: 16 929 845 | Sell: 55 923 583

Forecast: 16:00 - $1.651

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $1.651
Forecast 2: 16:00 - $1.651
Forecast 3: 16:00 - $1.651
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.650 (0.00% )
Volume 0.0441 mill
Avg. Vol. 0.378 mill
% of Avg. Vol 11.68 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Reneo Pharmaceuticals, Inc. Common Stock

Last 12 Months

Last 12 months chart data with high, low, open and close for Reneo Pharmaceuticals, Inc. Common Stock

RSI

Intraday RSI14 chart for Reneo Pharmaceuticals, Inc. Common Stock

Last 10 Buy & Sell Signals For RPHM

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:30sell$1.650N/AActive
Profile picture for
            Reneo Pharmaceuticals, Inc. Common Stock

RPHM

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Last 10 Buy Signals

Date Signal @
RADUSDMar 28 - 06:49$3.16
IONUSDMar 28 - 06:48452.58
HAPIUSDMar 28 - 06:4923.52
JUVUSDMar 28 - 06:432.87
STORJUSDMar 28 - 06:46$0.814
RLCUSDMar 28 - 06:46$3.85
FETUSDMar 28 - 06:46$3.31
SUIUSDMar 28 - 06:442.00
UQCUSDMar 28 - 06:44$9.08
SSVUSDMar 28 - 06:4459.17

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.